60 online
 
Most Popular Choices
Share on Facebook 160 Printer Friendly Page More Sharing
General News    H4'ed 2/22/10

Glaxo Birth Defect Litigation Reveals Paxil Promoters on Speed Dial

By       (Page 4 of 21 pages) Become a premium member to see this article and all articles as one long page.   No comments
Message Evelyn Pringle

"These are the doctors that are writing the literature that is out there in the peer-reviewed literature that doctors are relying on," he told the judge.


These doctors were required ethically "by their universities to disclose to the Federal Government how much money GSK was paying them," Tracey said. "They did not do that."


He also wanted the jury to know that "Emory University has actually stripped Doctor Nemeroff of his chair over this very issue of failing to disclose payments from GSK," he told the judge.


Tracey wanted to prove these allegations with testimony from Healy about Senator Charles Grassley's investigation of Nemeroff and Stowe and the results that were made public. In the end, the judge refused to allow Healy to testify about the amounts Nemeroff and Stowe were paid by Glaxo, why Nemeroff lost the chairmanship, or the disciplining of Stowe.


"Whether or not Emory had a battle with them about disclosure is not relevant in my mind,"the judge told Tracey. "What is relevant is that they were prominent individuals who wrote in favor of this drug, that they were on the advisory board, that they received honorariums of money, and that he believes in his opinion that these articles are wrong that they wrote."


"He can offer his opinion that they were wrong and why they were wrong," he said. "I am going to keep out the argument about the doctors being sanctioned for failing to disclose."


Nemeroff's "credibility from Emory would involve a mini trial of the issue with Emory and him," the judge said.


The Emory investigation, in fact, found Nemeroff was paid more than $960,000 by Glaxo, from 2000 through 2006, but listed less than $35,000 on his disclosure forms. All totaled, he had earnings of $2.8 million from speaking and consulting arrangements with drug companies between 2000 and 2007, but failed to disclose at least $1.2 million, according to Senate Finance Committee reports.


Next Page  1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Must Read 1   Interesting 1   Valuable 1  
Rate It | View Ratings

Evelyn Pringle Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Evelyn Pringle is an investigative journalist and researcher focused on exposing corruption in government and corporate America.
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

Tracking the American Epidemic of Mental Illness - Part II

Tracking the American Epidemic of Mental Illness - Part I

The Rise and Fall of Provigil -" Part I

The Rise and Fall of Provigil - Part II

Psychiatric Drugging of Infants and Toddlers in the US - Part I

Tracking the American Epidemic of Mental Illness - Part III

To View Comments or Join the Conversation:

Tell A Friend